You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

心通醫療(02160.HK)自研二尖瓣置換系統多例隨訪結果優異

阿思達克 08-06 20:42
心通醫療-B(02160.HK)公布,集團自主研發的經導管二尖瓣置換系統正推進臨床應用,並已成功用於救治多名重度患者,結果令人振奮,均實現二尖瓣反流顯著降低、無反覆,無瓣周漏,無左室流出道梗阻,心功能相關指標明顯改善。